ORGO
Organogenesis·NASDAQ
--
--(--)
--
--(--)
3.86 / 10
Netural
Fund flow evaluation scores 7.72/10, reflecting robust money inflows despite negative trends in most size brackets (Small, Medium, Large, Extra-large). Analyst perspectives are overwhelmingly bullish with a 100% Strong Buy rating from two assessments, yet historical win rates are low. This divergence between positive sentiment and mixed historical performance underscores caution in relying solely on current fund-flow or analyst momentum.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-26
InstitutionBTIG
Times predicted4
Historical Win Rate0.0%
What is the analyst consensus for ORGO?
- ORGO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.86/10 (Netural).
